Clinical Significance and Treatment Requirements in White Coat and Masked Hypertension
Author:
Mallion Jean-Michel
Reference60 articles.
1. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
2. Pickering TG, James GD, Boddie C et al (1988) How common is white coat hypertension? JAMA 259:225–228
3. Mancia G, Zanchetti A (1996) White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? (editorial). J Hypertens 14:1049–1052
4. Verdecchia P, Schillaci G, Borgioni C et al (1995) White coat hypertension and white coat effect similarities and differences. Am J Hypertens 8:790–798
5. Pierdomenico SD, Mezzetti A, Lapenna D et al (1995) ‘White-coat’ hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 16:692–697